Sepsis Clinical Trial Landscape
Data updated: May 20, 2026
484 clinical trials tracked since 2008
Sepsis is being studied across 484 clinical trials registered since 2008, with 116 programs currently active. The competitive pipeline includes 31 active Phase 3 trials, 41 active Phase 2 trials, and 16 active Phase 1 trials. Top industry sponsors include Bayer, AstraZeneca, ImmunityBio, Inc..
116 active
/
484 total (since 2008)
16
Phase 1 Active
78 total
41
Phase 2 Active
184 total
31
Phase 3 Active
159 total
42
Phase 4 Active
128 total
Top Industry Sponsors
Sorted by active Active Done Failed
Bayer 2 0 0
AstraZeneca 1 3 0
ImmunityBio, Inc. 1 0 2
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. 1 0 0
Op-T LLC 1 0 0
+ 6 more sponsors — see full table below
Featured Phase 3 Trials
NCT07530146 RECRUITING
Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation
Helwan University n=41
NCT06592586 ACTIVE NOT RECRUITING
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Minervax ApS n=338
NCT07264543 RECRUITING
Early Methylene Blue in the Microhemodynamics of Septic Patients
Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva n=50
NCT04031573 ACTIVE NOT RECRUITING
Ivabradine for Heart Rate Control In Septic Shock
Assistance Publique - Hôpitaux de Paris n=429
NCT05267821 RECRUITING
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
Nationwide Children's Hospital n=500
+ 154 more Phase 3 trials — see full database below
Sepsis — Trials Started by Year (last 10 years)
2016 23
2017 26
2018 33
2019 39
2020 29
2021 24
2022 23
2023 26
2024 31
2025 27
2026 38
TheraRadar.com
Full Trial Database
Complete sponsor table, every trial across all phases, plus competitive analytics. Sortable, filterable, exportable for Pro users.
Top Sponsors (all-time)
Bayer 2
AstraZeneca 4
ImmunityBio, Inc. 3
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. 1
Op-T LLC 1
Artcline GmbH 1
Vivacelle Bio 1
Grand Medical Pty Ltd. 1
Dascena 3
Ferring Pharmaceuticals 3
Active Trials by Phase
Phase 1 16
Phase 2 41
Phase 3 31
Phase 4 42
Enrollment Size Distribution
1-50 167
51-200 158
201-500 80
501-1k 17
1k+ 33
All Industry Sponsors
Sorted by active Active Done Failed
Bayer 2 0 0
AstraZeneca 1 3 0
ImmunityBio, Inc. 1 0 2
Shanghai Yidian Pharmaceutical Technology Development Co., Ltd. 1 0 0
Op-T LLC 1 0 0
Artcline GmbH 1 0 0
Vivacelle Bio 1 0 0
Grand Medical Pty Ltd. 1 0 0
Dascena 0 0 3
Ferring Pharmaceuticals 0 2 1
Bristol-Myers Squibb 0 2 1
NCT07569536 NOT YET RECRUITING
Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock
Hospices Civils de Lyon n=360
NCT07550894 NOT YET RECRUITING
Phosphate-Containing Replacement Fluid for Patients Undergoing CRRT
Sun Yat-sen University n=220
NCT07530146 RECRUITING
Comparative Efficacy and Safety of Propofol-Ketamine Combination Versus Propofol Monotherapy in Geriatric Patients Under Invasive Ventilation
Helwan University n=41
NCT06592586 ACTIVE NOT RECRUITING
A Follow-up Trial of GBS-NN/NN2 Vaccine in Healthy Pregnant Women
Minervax ApS n=338
NCT07264543 RECRUITING
Early Methylene Blue in the Microhemodynamics of Septic Patients
Centro de Estudos e Pesquisa em Emergencias Medicas e Terapia Intensiva n=50
NCT07488689 NOT YET RECRUITING
Assessing the Efficacy of Dapagliflozin as a Vasculoprotective Treatment in Septic Shock Patients With Microcirculatory Dysfunction
University Hospital, Strasbourg, France n=568
NCT04031573 ACTIVE NOT RECRUITING
Ivabradine for Heart Rate Control In Septic Shock
Assistance Publique - Hôpitaux de Paris n=429
NCT05267821 RECRUITING
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
Nationwide Children's Hospital n=500
NCT07380347 NOT YET RECRUITING
Effect of N-acetylcysteine as Adjunct Therapy on the Clinical Outcome of Neonatal Sepsis
Ain Shams University n=50
NCT06464510 RECRUITING
Norepinephrine and Vasopressin for Rescue Versus Early Vasopressin for Vasopressor Dependent Sepsis
Hospital do Coracao n=2,800
NCT05909683 ACTIVE NOT RECRUITING
Assessing the Procalcitonin-guidance and Molecular-guided Diagnosis for Therapy of Severe Infections (the MODIFY Trial)
Hellenic Institute for the Study of Sepsis n=190
NCT07342205 RECRUITING
A Study on the Treatment of Patients With Acute Lung Injury Caused by Sepsis Through Microbiota Transplantation
Shanghai University of Traditional Chinese Medicine n=60
NCT07332325 NOT YET RECRUITING
STeroids and Enhanced Spectrum Antibiotics for the Treatment of Patients in Africa With Refractory Sepsis
University of Virginia n=344
NCT07067866 RECRUITING
Weaning Approaches for Vasopressin in Sepsis
Hospital Nossa Senhora da Conceicao n=82
NCT07212582 NOT YET RECRUITING
Human Albumin for Resuscitation in Surgical Septic Shock: A Randomized Controlled Trial (ALBUS Study)
Mahidol University n=304
NCT07063095 RECRUITING
A Combination Therapy With Ceftazidime and Fosfomycin Will be Compared to Ceftazidime Alone in Hospitalized Adult Patients With Suspected Severe Gram-negative Bacterial Infections
Angela HUTTNER n=100
NCT04589546 ACTIVE NOT RECRUITING
Does High-dose Vitamin B3 Supplementation Prevent Major Adverse Kidney Events During Septic Shock?
Centre Hospitalier Universitaire, Amiens n=310
NCT04748796 RECRUITING
Comparison of Landiolol Versus Standard of Care for Prevention of Mortality in Patients Hospitalized for a Septic Shock With Hypercontractility
Centre Hospitalier Universitaire, Amiens n=360
NCT07052084 NOT YET RECRUITING
Systematic Adjunction of Vasopressine in Septic Shock
Assistance Publique Hopitaux De Marseille n=120
NCT04910464 RECRUITING
Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis
Assiut University n=80
NCT04931225 RECRUITING
LANdiolol MIcrocirculatory Effects During Septic chOc (MILANOS)
Assistance Publique - Hôpitaux de Paris n=44
NCT06893939 RECRUITING
Limited Versus Extended Trophic Feeding (LET-FEED) Trial
University of Washington n=350
NCT06072430 RECRUITING
A Phase III, Open Label, Randomized, Controlled Study of VBI-S in the Treatment of Hypovolemia in Patients With Septic Shock (VBI-S-02)
Vivacelle Bio n=46
NCT06851078 NOT YET RECRUITING
Evaluation of Early Administration of Levetiracetam in the Prevention and Treatment Encephalopathy in Septic Shock: Randomized, Double-blind, Placebo-controlled Trial
Assistance Publique - Hôpitaux de Paris n=280
NCT06696391 NOT YET RECRUITING
Venous Excess Ultrasound for Personalized Resuscitation in Septic Shock
Western University, Canada n=80
NCT03797157 ACTIVE NOT RECRUITING
Human Milk Fortification in Extremely Preterm Infants
Thomas Abrahamsson, MD, PhD n=229
NCT06377397 NOT YET RECRUITING
Selective Antibiotics When Symptoms Develop Versus Universal Antibiotics for Preterm Neonates
Indian Council of Medical Research n=1,500
NCT06306001 NOT YET RECRUITING
Intravenous Methylene Blue for Treating Refractory Neonatal Septic Shock
Post Graduate Institute of Medical Education and Research, Chandigarh n=130
NCT05565222 RECRUITING
Piperacillin-tazobactam and Temocillin as Carbapenem-alternatives for the Treatment of Severe Infections Due to Extended-spectrum Beta-lactamase-Producing Gram-negative Enterobacteriaceae in the Intensive Care Unit
Assistance Publique - Hôpitaux de Paris n=600
NCT07492875 WITHDRAWN
Study of Nogapendekin Alfa Inbakicept and iNKT Cells in Critically Ill Adults With Severe Community-Acquired Pneumonia
ImmunityBio, Inc.
NCT01626612 COMPLETED
De-escalation of Empirical Antimicrobial Therapy Study in Severe Sepsis
Assistance Publique Hopitaux De Marseille n=120
NCT05266001 COMPLETED
GM-CSF for Reversal of Immunoparalysis in Pediatric Sepsis-induced MODS
Nationwide Children's Hospital n=141
NCT01682590 TERMINATED
I.D.E.A.L.-I.C.U. (Initiation of Dialysis EArly Versus deLayed in Intensive Care Unit)
Centre Hospitalier Universitaire Dijon n=500
NCT05208242 COMPLETED
Strong Albumin Solutions in Patients With Septic Shock
Manchester University NHS Foundation Trust n=47
NCT06532240 COMPLETED
Methylene Blue for the Treatment of Septic Shock
Northern Jiangsu People's Hospital n=88
NCT03953677 TERMINATED
Evaluation of the Effect of Dexmedetomidine on Phenylephrine Response During Refractory Septic Shock
Centre Hospitalier Universitaire Dijon n=32
NCT03528213 COMPLETED
Utility of Sodium Lactate Infusion During Septic Shock
University Hospital, Lille n=59
NCT04166331 COMPLETED
Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion
University Hospital, Limoges n=136
NCT02473263 COMPLETED
Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic Shock
Assistance Publique - Hôpitaux de Paris n=398
NCT02664753 TERMINATED
L-carnitine as an Adjunct Treatment for Septic Shock Patients With Acute Kidney Injury
Centre Hospitalier Universitaire de Nīmes n=254
NCT05856227 COMPLETED
Late-onset Sepsis in Term and Pre-term Neonates and Infants up to 3 Months of Age
Basilea Pharmaceutica n=9
NCT06122909 COMPLETED
The Effect Of Resuscitation Guided By Two Different Dynamic Parameters On Time To Normalization Of The Capillary Refill Time In Adult Patients With Septic Shock
Kasr El Aini Hospital n=90
NCT04172012 COMPLETED
Use of Probiotics to Reduce Infections, Death and ESBL Colonisation
Haydom Lutheran Hospital n=2,000
NCT03654001 COMPLETED
ALBumin Italian Outcome Septic Shock-BALANCED Trial (ALBIOSS-BALANCED)
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico n=1,319
NCT02820987 COMPLETED
PK/PD of Extended-infusion Meropenem, Piperacillin-tazobactam and Cefepime in the Early Phase of Septic Shock
Centre Hospitalier Universitaire de Besancon n=119
NCT04475081 COMPLETED
Use of a Live Attenuated Vaccine as an Immune-based Preventive Against COVID-19-associated Sepsis
Louisiana State University Health Sciences Center in New Orleans n=50
NCT05955612 COMPLETED
Use of Procalcitonin, a Blood Test to Guide Antibiotic Therapy for Sepsis in Adults
University of Oxford n=532
NCT03871491 COMPLETED
Azithromycin-Prevention in Labor Use Study (A-PLUS)
NICHD Global Network for Women's and Children's Health n=58,747
NCT04540094 COMPLETED
Feasibility of 5% Albumin Compared With Balanced Crystalloid, as Intravenous Fluid Resuscitation in Adult Patients With Sepsis, Presenting as an Emergency to Hospital
University of Edinburgh n=300
NCT04152980 COMPLETED
Pentoxifylline Dose Optimization in Neonatal Sepsis
Erasmus Medical Center n=30
NCT06005558 COMPLETED
Low Dose Versus High Dose Methylene Blue in Septic Patients
National Cancer Institute, Egypt n=90
NCT03788837 COMPLETED
ILOPROST in Septic Shock With Persistent Microperfusion Defects (I-MICRO)
Assistance Publique - Hôpitaux de Paris n=240
NCT03837171 COMPLETED
TRANSfusion in Patients With Onco-hematological Malignancies ResusciTated From Septic Shock
Assistance Publique - Hôpitaux de Paris n=192
NCT06461390 COMPLETED
The Effect of Early Norepinephrine on Stroke Volume Index, Cardiac Index, Lactate, and Arterial Elastance in Pediatric Septic Shock
Indonesia University n=42
NCT04123444 COMPLETED
Infusion of Prostacyclin (Iloprost) vs Placebo for 72-hours in Patients With Septic Shock Suffering From Organ Failure
Jakob Stensballe, MD, PhD n=279
NCT05192213 TERMINATED
Vitamin C, Hydrocortisone and Thiamine in Patients With Septic Shock
Hospital Sirio-Libanes n=71
NCT04747795 COMPLETED
Early Administration of Vitamin C in Patients With Sepsis or Septic Shock in Emergency Departments
Universitaire Ziekenhuizen KU Leuven n=301
NCT03452865 COMPLETED
Esomeprazole to Reduce Organ Failure in Sepsis
Università Vita-Salute San Raffaele n=300
NCT03835286 WITHDRAWN
Vitamin C to Reduce Vasopressor Dose in Septic Shock
Hospital Español de Mexico
NCT04724044 COMPLETED
Anti-inflammatory Action of Oral Clarithromycin in Community-acquired Pneumonia
Hellenic Institute for the Study of Sepsis n=278
NCT05001854 SUSPENDED
Hemodynamics Effects of Fludrocortisone on the Pressor Response to Noradrenaline Septic Shock Patients
Rennes University Hospital n=40
NCT03280147 COMPLETED
7 Days Versus 14 Days of Antibiotics for Neonatal Sepsis
Indian Council of Medical Research n=261
NCT05558098 COMPLETED
Dapagliflozin in Patients With Critical Illness
Hospital Israelita Albert Einstein n=507
NCT04111822 COMPLETED
Pilot Study on the Use of Hydrocortisone, Vitamin c and Tiamine in Patient With Sepsis and Septic Shock
Cristina Martinez n=40
NCT05969327 COMPLETED
Role of Vitamin D Therapy in Recovery From Early Neonatal Sepsis (Randomized Controlled Trial)
Ain Shams University n=66
NCT02389036 COMPLETED
Selective Decontamination of the Digestive Tract in Intensive Care Unit Patients
The George Institute n=20,010
NCT03434028 COMPLETED
Crystalloid Liberal or Vasopressors Early Resuscitation in Sepsis
Massachusetts General Hospital n=1,563
NCT04742764 SUSPENDED
Extracorporal Cytokin Removal in Septic Shock: a Prospective, Randomized, Multicenter Clinical Trial
University of Pecs n=135
NCT04643639 COMPLETED
Assessing the Effects of CytoSorb Hemoperfusion on the Development on Immunoparalysis
Radboud University Medical Center n=24
NCT05596942 COMPLETED
Evaluating the Efficacy of Channa Striata in Stabilizing eNOS in Patients With Septic.
Universitas Sebelas Maret n=42
NCT04088591 WITHDRAWN
High-dose Intravenous Vitamin C as an Adjunctive Treatment for Sepsis in Rwanda
Virginia Commonwealth University
NCT03199547 COMPLETED
Pre-delivery Administration of Azithromycin to Prevent Neonatal Sepsis & Death
London School of Hygiene and Tropical Medicine n=11,985
NCT03380507 TERMINATED
Evaluation of Hydrocortisone, Vitamin C and Thiamine for the Treatment of Septic Shock
Hamad Medical Corporation n=106
NCT01525316 COMPLETED
Lactoferrin for Prevention of Sepsis in Infants
Universidad Peruana Cayetano Heredia n=414
NCT04346693 COMPLETED
An Open Randomized Study of Dalargin Efectiveness in Combination With Leitragin Drug in Patients With Severe and Critical Manifestations of SARS-COVID-19
Burnasyan Federal Medical Biophysical Center n=320
NCT03872011 COMPLETED
Vitamin C, Thiamine and Hydrocortisone for the Treatment of Septic Shock
Northern Jiangsu People's Hospital n=408
NCT01739933 COMPLETED
The MENDS2 Study, Maximizing the Efficacy of Sedation and Reducing Neurological Dysfunction and Mortality in Septic Patients With Acute Respiratory Failure
Vanderbilt University Medical Center n=438
NCT02684487 WITHDRAWN
Vitamin D Status in Patients With Severe Sepsis
Massachusetts General Hospital
NCT02508649 TERMINATED
Selepressin Evaluation Programme for Sepsis-Induced Shock - Adaptive Clinical Trial
Ferring Pharmaceuticals n=868
NCT03277677 COMPLETED
The Effect of Fluid Resuscitation With 0.9% Sodium Chloride Versus Balanced Crystalloid Solution on Renal Function of Sepsis Patients
Chulalongkorn University n=116
NCT02330432 COMPLETED
Mycobacterium w in Patients With Severe Sepsis
Post Graduate Institute of Medical Education and Research, Chandigarh n=202
NCT03389555 COMPLETED
Ascorbic Acid, Corticosteroids, and Thiamine in Sepsis (ACTS) Trial
Beth Israel Deaconess Medical Center n=205
NCT04508946 COMPLETED
Triple Therapy in Septic Shock Patients
Air Force Specialized Hospital, Cairo, Egypt n=94
NCT02714595 COMPLETED
Study of Cefiderocol (S-649266) or Best Available Therapy for the Treatment of Severe Infections Caused by Carbapenem-resistant Gram-negative Pathogens
Shionogi n=152
NCT03345992 COMPLETED
Benefit of Clarithromycin in Patients With Severe Infections Through Modulation of the Immune System
Hellenic Institute for the Study of Sepsis n=110
NCT04197115 COMPLETED
Vitamin C, Thiamine, Cyanocobalamine, Pyridoxine and Hydrocortisone in Sepsis
IMSS Hospital General de Zona 11, Piedras Negras n=19
NCT01598831 COMPLETED
Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
Asahi Kasei Pharma America Corporation n=816
NCT01817153 TERMINATED
Effect of Hydrocortison on Post-ischemic Flow-mediated Dilation and on Thenar Oxygen Saturation in Human Septic Shock.
Centre Hospitalier Régional d'Orléans n=10
NCT03828929 TERMINATED
Effect of IV Vitamin C, Thiamine, and Steroids on Mortality of Septic Shock
New York Presbyterian Brooklyn Methodist Hospital n=3
NCT03844984 COMPLETED
Lidocaine-Ketamine Versus Ketamine for Induction of Anesthesia in Septic Shock Patients
Cairo University n=43
NCT03517501 WITHDRAWN
The Safety And Efficacy of ART-123 in Subjects With Sepsis and Coagulopathy
Asahi Kasei Pharma America Corporation
NCT03104140 COMPLETED
Ketamine Versus Low Dose Thiopental for Induction of Anesthesia in Septic Shock
Cairo University n=26
NCT01718613 COMPLETED
Vasopressin Versus Norepinephrine for the Management of Septic Shock in Cancer Patients
Instituto do Cancer do Estado de São Paulo n=250
NCT01177111 COMPLETED
Impact of Sunflower Seed Oil Massage on Neonatal Mortality and Morbidity in Nepal
Johns Hopkins Bloomberg School of Public Health n=29,260
NCT01337934 COMPLETED
Lactated Ringer Versus Albumin in Early Sepsis Therapy
University of Sao Paulo n=360
NCT02338843 COMPLETED
A Phase 3 Study of LJPC-501 in Patients With Catecholamine-Resistant Hypotension
La Jolla Pharmaceutical Company n=344
NCT01649921 COMPLETED
The Effects of Interferon-gamma on Sepsis-induced Immunoparalysis
Radboud University Medical Center n=4
NCT01856517 TERMINATED
Upregulation of Alpha-1 Receptors Upon Septic Shock?
Direction Centrale du Service de Santé des Armées n=40
NCT00676897 COMPLETED
Statin Therapy in the Treatment of Sepsis
Beth Israel Deaconess Medical Center n=18
NCT00625209 COMPLETED
Activated Protein C and Corticosteroids for Human Septic Shock
University of Versailles n=1,241
NCT02336620 COMPLETED
Balanced Salt Solution VS. Normal Saline Solution in Septic Shock
Ramathibodi Hospital n=60
NCT02638545 COMPLETED
Hemodynamic Effects of Dexmedetomidine in Septic Shock
University of Roma La Sapienza n=37
NCT01633294 COMPLETED
Antibiotic Prophylaxis in Prelabor Rupture of Membranes at Term
Hospital de Santa Maria, Portugal n=161
NCT01455116 TERMINATED
The Cooling And Surviving Septic Shock Study (CASS)
Danish Procalcitonin Study Group n=433
NCT02954926 COMPLETED
Intravenous Immunoglobulin in Prevention of Preterm Neonatal Sepsis
Hormozgan University of Medical Sciences n=92
NCT00832039 COMPLETED
Placebo Controlled Trial of Sodium Selenite and Procalcitonin Guided Antimicrobial Therapy in Severe Sepsis
Kompetenznetz Sepsis n=1,089
NCT01723501 WITHDRAWN
Chlorhexidine Skin Application for Prevention of Infection in Infants Weighing <1500 g at Birth
All India Institute of Medical Sciences
NCT00979121 TERMINATED
Statins for Acutely Injured Lungs From Sepsis
National Heart, Lung, and Blood Institute (NHLBI) n=745
NCT01705808 TERMINATED
Administration of Protein C Concentrates in Adult Critically Ill Septic Patients
Università Vita-Salute San Raffaele
NCT00707122 COMPLETED
Volume Replacement With Albumin in Severe Sepsis
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico n=1,818
NCT02503761 COMPLETED
Bolus Versus Prolonged Infusion of Meropenem in Newborn With Late Onset Sepsis
Mansoura University n=100
NCT01027429 COMPLETED
Simplified Antibiotic Therapy for Sepsis in Young Infants
Aga Khan University n=2,543
NCT01801020 WITHDRAWN
Different Modes of Temperature Measurement in the Emergency Department
HaEmek Medical Center, Israel
NCT01551394 COMPLETED
Efficacy, Pharmacokinetics and Safety of Meropenem in Infants Below 90 Days With Clinical or Confirmed Late-onset Sepsis
PENTA Foundation n=272
NCT01275976 TERMINATED
Effect of C1-esterase Inhibitor on Systemic Inflammation in Trauma Patients With a Femur or Pelvic Fracture
UMC Utrecht n=11
NCT00901940 COMPLETED
Understanding the Immune Response to Meningitis Vaccines
University of Oxford n=150
NCT01766414 COMPLETED
In Vivo Effects of C1-esterase Inhibitor on the Innate Immune Response During Human Endotoxemia - VECTOR II
Radboud University Medical Center n=20
NCT02266589 COMPLETED
Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock
Nanjing PLA General Hospital n=84
NCT01485315 COMPLETED
Transfusion-requirements in Septic Shock Trial
Scandinavian Critical Care Trials Group n=1,005
NCT02135770 COMPLETED
Impact of Low Dose Unfractionated Heparin Treatment on Inflammation in Sepsis
Indonesia University n=115
NCT02163174 COMPLETED
Pentoxifylline and Late Onset Sepsis in Preterm Infants
Abd Elazeez Attala Shabaan n=120
NCT01359813 TERMINATED
Albumin Administration in Cirrhotic Patients With Bacterial Infection and a Systemic Inflammatory Response Syndrome Unrelated to Spontaneous Bacterial Peritonitis
Centre Hospitalier Universitaire de Besancon n=193
NCT01329887 COMPLETED
The Effect of Ketanserin on the Microcirculation in Sepsis
Frisius Medisch Centrum n=10
NCT02114710 COMPLETED
Effects of Stress Doses of Hydrocortisone on Coagulation Dysfunction in Patients With Septic Shock
Nanjing PLA General Hospital n=240
NCT02025660 COMPLETED
Efficacy of Mw Vaccine in Treatment of Severe Sepsis
Post Graduate Institute of Medical Education and Research, Chandigarh n=50
NCT01271114 TERMINATED
Hypertonic Saline and Terlipressin for Sepsis-associated Hypotension
Hospital General de Ciudad Real n=21
NCT01862185 COMPLETED
The Effect of Semi-quantitative Procalcitonin Assay to The Adequacy of Empirical Antibiotics and Mortality in Septic Patients
Indonesia University n=205
NCT01222663 COMPLETED
Effects of Hemoperfusion With a Polymyxin B Membrane in Peritonitis With Septic Shock
Meditor SAS n=243
NCT00670254 COMPLETED
Hydrocortisone for Prevention of Septic Shock
Charite University, Berlin, Germany n=380
NCT00608322 COMPLETED
Randomized Trial of Inhaled Nitric Oxide to Augment Tissue Perfusion in Sepsis
National Institute of General Medical Sciences (NIGMS) n=49
NCT01315496 TERMINATED
GCIV as an Adjuvant Therapy for Community-Acquired Severe Sepsis or Septic Shock
Green Cross Corporation n=214
NCT00633477 TERMINATED
Efficacy and Safety of Resatorvid in Patients With Sepsis-induced Cardiovascular and Respiratory Failure
Takeda n=18
NCT00604214 COMPLETED
Efficacy and Safety of Drotrecogin Alfa (Activated) in Adult Patients With Septic Shock
Eli Lilly and Company n=1,696
NCT01273779 SUSPENDED
Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
Agennix n=1,280
NCT00646399 COMPLETED
Safety and Efficacy of Pagibaximab Injection in Very Low Birth Weight Neonates for Prevention of Staphylococcal Sepsis
Biosynexus Incorporated n=1,579
NCT01067313 COMPLETED
Continuous Hemodialysis With an Enhanced Middle Molecule Clearance Membrane
Fresenius Medical Care France n=24
NCT00995839 COMPLETED
Terlipressin in Septic Shock: Effects on Microcirculation
University of Roma La Sapienza n=60
Data: ClinicalTrials.gov · Trials registered 2008 onwards · Industry sponsors only